Answers are grounded in this paper and cite their sources.
Purpose The aim of this study was to investigate the relationship between malnutrition, diagnosed using GLIM criteria, and SF-36 General Health score among patients with colorectal (CRC) and other digestive cancers and to evaluate the combined prognostic association of malnutrition and QoL with survival at 90 days and 1 year after discharge. Methods In a prospective cohort of 519 cancer patients, nutritional status was assessed using MUST and GLIM criteria. QoL was measured with the SF-36 and EuroQol questionnaires, and functional status with the Barthel Index. Survival was estimated using the Kaplan–Meier method, and Cox regression identified prognostic factors. Results Patients were 62% male with a mean age of 67.9 years; 23.51% were moderately and 21.97% severely malnourished. The most prevalent diagnosis was CRC (65.5%). Patients had moderate functional status and QoL scores at admission. Mortality was 12.5% at 90 days and 27% at 1 year. Combined low SF-36 General Health score and malnutrition was associated with 90-day mortality (HR = 6.03, p < 0.001), followed by low SF-36 General Health score without malnutrition (HR = 3.4, p < 0.05). Longer hospital stay and medical complications were associated with increased mortality, while surgery was associated with lower mortality (HR = 0.38, 95% CI 0.19–0.76, p < 0.001). At 1 year, age, CCI, stage IV cancer, and complications remained key mortality-associated factors. The impact of SF-36 General Health score was weaker than at 90 days but combined poor SF-36 General Health score and malnutrition remained significant. Models showed strong discrimination ( C -Index > 0.80). Conclusions Combined assessment of GLIM-defined malnutrition and self-reported general health may help identify hospitalised patients with digestive cancer who are at increased risk of post-discharge mortality. Implications for cancer survivors Whether interventions based on this risk stratification improve outcomes requires prospective interventional evaluation. Trial registration ClinicalTrials.gov as ID NCT04188990. Registration date: 2 December 2019.
No takes yet. Share an insight, caveat, or question.
Martín et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: